Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.


TSX:SVA - Post by User

Comment by Sailboatdreamon Mar 03, 2022 3:16pm
248 Views
Post# 34480379

RE:RE:RE:RE:RE:Snooze Fest

RE:RE:RE:RE:RE:Snooze Fest

Benefit of the doubt ended on Feb 28 for me.  Now contemplating next steps.  Potential of the pouch, it's applications, conformal coating and stem cells all well understood.  So selling at this point seems last resort for me.  But leading up to AGM in June, I am open to any other course of action.  Certainly not happy with business related track record.  Hope and Patience are not what management is being for.   They are paid for results.  And the results (including TSX listing) are clearly not there.   Even the new IR guy came in with a splash touting institutional investments as his no. 1 priority.  Which did produce 2 detailed reports.  Except Industrial Alliance dumped 200k shares 2 weeks after publishing the report.  As if we wouldn't notice.  

I have said it before... Philip was instrumental in bringing the company this far.  But now time for a new CEO profile.  A closer.  And Frank's involvement over the past 5 months does not seem to have helped.  

<< Previous
Bullboard Posts
Next >>